Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2000, p. 2842-2844, Vol. 44, No. 10
Institute of Infectious Diseases and Public
Health,1 and Department of General
Surgery, I.N.R.C.A.I.R.R.C.S.,2 University of
Ancona, and Biotechnology Center, Research Department,
I.N.R.C.A. I.R.R.C.S.,3 Ancona, Italy
Received 28 February 2000/Returned for modification 5 June
2000/Accepted 6 July 2000
A rat model was used to investigate the efficacy of mupirocin in
the prevention of vascular prosthetic graft infection due to
Staphylococcus epidermidis strains with different
susceptibility patterns (methicillin susceptible, methicillin
resistant, and with intermediate resistance to vancomycin). The effect
of mupirocin-soaked Dacron was compared to that of perioperative
intraperitoneal prophylaxis with vancomycin. Graft infections were
established in the back subcutaneous tissue of adult male Wistar rats
by implantation of Dacron prostheses (1 cm2) followed by
topical inoculation with 5 × 107 CFU of one
staphylococcal strain. The study included a control group (no graft
contamination), three contaminated groups that did not receive any
antibiotic prophylaxis, three contaminated groups that received
mupirocin-soaked grafts, three contaminated groups in which
perioperative intraperitoneal vancomycin prophylaxis (10 mg/kg of body
weight) was administered, and three contaminated groups that received
mupirocin-soaked grafts and perioperative intraperitoneal vancomycin
prophylaxis (10 mg/kg). The grafts were sterilely removed 7 days after
implantation, and the infection was evaluated by using sonication and
quantitative agar culture. Data analysis showed the efficacy of
mupirocin against all three strains, with growth of the strains in
treated rats significantly different than that in the untreated
control. In addition, mupirocin was more effective than vancomycin
against the strain with intermediate susceptibility to the
glycopeptide. Finally, the combination of mupirocin and vancomycin
produced complete suppression of the growth of all of the strains.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mupirocin Prophylaxis against Methicillin-Susceptible,
Methicillin-Resistant, or Vancomycin-Intermediate
Staphylococcus epidermidis Vascular-Graft
Infection
*
Corresponding author. Mailing address: Clinica delle
Malattie Infettive, c/o Azienda Ospedaliera Umberto I, Piazza Cappelli, 1, 60121 Ancona, Italy. Phone: 39 071 5963467. Fax: 39 071 5963468. E-mail: cmalinf{at}popcsi.unian.it.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»